Learn About Parkinson's & Clinical Trials

Simple guides for families navigating Parkinson's research. No medical degree required. Written for caregivers and patients.

• Why I Built Parkinson's Pathways
• What Do Clinical Trial Phases Mean? A Simple Guide for Families
• What Do the Different Statuses Mean on a Parkinson's Clinical Trial Listing?
• How Long Does a Parkinson's Clinical Trial Last?
• How to Talk to Your Neurologist About Clinical Trials
• Just Diagnosed with Parkinson's? Here's Where to Start with Clinical Trials
• Stem Cell Therapy for Parkinson's: What You Should Actually Know
• Will My Family Member Get a Placebo?
• How Close Is a Cure for Parkinson's Disease?
• Parkinson's and Dementia: What Families Need to Know About Clinical Trials
• What to Expect in the First Year After a Parkinson's Diagnosis
• Diet and Parkinson's Risk: What the Research Says
• ClinicalTrials.gov vs Parkinson's Pathways: What's the Difference?
• Interventional vs Observational Parkinson's Trials: What's the Difference?
• Phase 1 vs Phase 2 vs Phase 3 Trials: What Each Stage Actually Looks Like
• Disease-Modifying vs Symptomatic Parkinson's Trials: What's the Difference?
• Industry-Sponsored vs Academic Medical Center Trials: What's the Difference?
• Clinical Trial vs Standard of Care: What Joining a Parkinson's Trial Actually Changes
• DBS vs Duopa vs Focused Ultrasound for Parkinson's: What's the Difference?
• Parkinson's vs Lewy Body Dementia vs PSP vs MSA: Telling Parkinsonisms Apart
• Parkinson's vs Essential Tremor: How to Tell Them Apart
• Levodopa vs Dopamine Agonists: What's the Difference?
• Sinemet IR vs CR vs Rytary vs Inbrija: Carbidopa-Levodopa Formulations Compared
• Tavapadon: The New Parkinson's Drug Awaiting FDA Approval in 2026
• GLP-1 Drugs in Parkinson's Research: What the Evidence Actually Says
• What Is Levodopa and How Does It Work?